Zyn can now market and put on the label and advertise that it is better for you than cigarettes, which is such a mild claim, but it's huge for the industry. If you know what this means, it's an extremely high bar.

It's not exactly the same as white nicotine pouches that actually don't have tobacco in them. But anyway, the FDA has to review each one. They reviewed Zyn and they gave them the MRTP approval. It's huge news for the industry. It's very good news. It's good news for everyone, I think. Anyway, the other news is that NVIDIA and Eli Lilly are building an AI lab, $1 billion lab for drug discovery in San Francisco. Eli Lilly CEO Dave Ricks talks about their data advantage.

Works every time. Works every, every single time. We keep debating this, this meta question of will they launch a, a financially incentivized prediction market or will it purely be for social clout? You're still in the camp of there's going to be real dollars. It just feels like the first time Meta—

With the Iridium acquisition, Rocket Lab is positioning itself to compete directly with SpaceX, which already operates a 10,000-satellite fleet.